Anonymous
Guest
Anonymous
Guest
What I find funny is everybody thinks we needed to be steered from disaster. Prior to the layoffs 6 months ago I dont think we were in bad shape at all. Solaraze was flat yes but starting to think the Rx volume we had on that wasnt bad at all and just staying flat with all we had to deal w/ like the FDA, competition and Managed care coverage that was getting worse maybe wasnt that bad of a job. Oxistat had grown alot since the merger and I feel didnt reach its peak especially in Podiatry where we were doing well and had more room for growth. Adoxa was a success but yes went generic but we knew that was coming. Apexion was growing each month in my territory and Veregen never took off but was growing but very very slowly. So you take all that vs. now . Now we are selling Solaraze w/ new very stiff and good competition. So Rx arent even going to stay flat they will decline and Veregen is still where it was Rx wise prior to the layoffs. So if anything NOW is when we are heading for diaster. Six months ago we had more brands some which were growing. Now we have a brand that will decline because of a new drug and Veregen even if it grows slightly wont offset the losses on Solaraze. Look it im not a rocket scientist and I am generally a positive person but I totally disagree. Six months ago we were way better off then we are Now. Couple that w/ faceless leadership and JW who yes needs a shot but doesnt have the experience we need right now. I know for a fact we were betteroff six months or a year ago.
That is true if you are just focusing on Pharmaderm. But many people who "cruise" this board are not from Pharmaderm, and their perspectives are not the same. Some areas have made good improvements. But I agree with you that Pharmaderm is facing a challenging time. And anyone who says it's not is delirious. Hopefully, we acquire something soon to create a new opportunity for the branded division.
And the "steering" comment above is misplaced. There is not much Pharmaderm management can do to avoid a total meltdown. This is going to depend 100% on an external event. Either we acquire some assets to fill out the bag, or partner something, or even switch gears to other specialties. But Solaraze and Veregen together are a guaranteed declining trend because Picato will diminish Solaraze faster than Veregen can grow.
We should be rooting for BD right about now.......